Together, these data imply that primary mRNA COVID-19 vaccination may drive T-cell responsiveness towards the CD4+ subset, whereas a priming SARS-CoV-2 infection may drive an increase in T-cell responsiveness more profoundly in the CD8+ subset. This evidence concerns the gene CD4 and COVID-19.